Clinical Trial Update: A Clinical Trial on Efficacy and Safety for Lobaplatin and Gemcitabine in Combination With Docetaxel in the Second-line Treatments on Advanced Osteosarcoma [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 2/3 study evaluating the combination of lobaplatin and gemcitabine with docetaxel for second-line treatment of adva…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Gemcitabine (Gemcitabine)
• Lobaplatin (lobaplatin)

Snippet

Sponsor: China Association of Osteosarcoma Chemotherapy | Conditions: Lobaplatin and Gemcitabine in Combination, Second-line Treatments on Advanced Osteosarcoma | Phase 2, Phase 3 | Status: UNKNOWN